Outpatient & Specialty Care Stocks' Q3 Earnings Review: agilon health (NYSE:AGL) and Industry Trends

Outpatient and specialty care stocks reported mixed Q3 results, with revenues beating consensus estimates by 0.9% on average. agilon health's (NYSE:AGL) Q3 revenue of $1.44 billion was down 1.1% YoY, exceeding analysts' expectations by 1%. Despite the top-line beat, the company missed EPS estimates and full-year EBITDA guidance. agilon health's stock is down 27% since reporting and trades at $0.53. The industry is expected to grow due to rising demand for outpatient services, advancements in medical technology, and a shift toward value-based care models.